NCT03917667View on ClinicalTrials.gov

Sarcopenia in Acute Care Patients: Protocol for Sarcopenia 9+

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

April 2, 2019

Primary Completion Date

June 1, 2022

Study Completion Date

June 1, 2022

Conditions
Sarcopenia
Interventions
DIAGNOSTIC_TEST

EWGSOP2

EWGSOP2 criteria (Writing Group for the European Working Group on Sarcopenia in Older People 2) will be followed to determine the diagnosis of sarcopenia, considered as a dichotomous variable -yes/no- in presence of low grip strength + low muscle mass + low gait speed.

Trial Locations (2)

1020

CHU Brugmann, Brussels

9000

UZ Gent, Ghent

All Listed Sponsors
lead

Murielle Surquin

OTHER

NCT03917667 - Sarcopenia in Acute Care Patients: Protocol for Sarcopenia 9+ | Biotech Hunter | Biotech Hunter